Blueshift Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Blueshift Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,523	Closed	-$162K	–	837
2022 Q2	$162K	Sell	11,523 -1,529	-12%	-$21.8K	0.03%	596
2022 Q1	$187K	Buy	+13,052	New	+$192K	0.02%	742
2021 Q1	–	Sell	-23,680	Closed	-$431K	–	1067
2020 Q4	$431K	Sell	23,680 -25,401	-52%	-$446K	0.05%	443
2020 Q3	$876K	Buy	+49,081	New	+$894K	0.12%	233
2020 Q1	–	Sell	-71,217	Closed	-$1.41M	–	642
2019 Q4	$1.41M	Buy	+71,217	New	+$1.36M	0.16%	195
2019 Q3	–	Sell	-33,232	Closed	-$588K	–	951
2019 Q2	$588K	Sell	33,232 -5,759	-15%	-$105K	0.08%	369
2019 Q1	$794K	Buy	+38,991	New	+$785K	0.11%	295

Other funds holding TAK

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Blueshift Asset Management's TAK Position: Q3 2022 in Review

Blueshift Asset Management sold out of Takeda Pharmaceutical (TAK) in Q3 2022, closing a stake of 11,523 shares — an estimated $162K sold.

Blueshift Asset Management first reported a position in TAK in Q1 2019 and held it in 7 quarters. The position peaked at $1.41M in Q4 2019. 276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

Blueshift Asset Management reported no remaining Takeda Pharmaceutical position as of Q3 2022 after selling out during the quarter.
Blueshift Asset Management sold 11,523 Takeda Pharmaceutical shares in Q3 2022, an estimated $162K.
Blueshift Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 7 quarters.
Blueshift Asset Management's Takeda Pharmaceutical position peaked at $1.41M in Q4 2019.
276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.